Farms.com Home   News

Farm Groups Want Canada To Assume Key Role In TPP Negotiations

 
A number of Canadian farm groups are urging the federal government to advance the Trans Pacific Partnership (TPP) next week during meetings to be held in Vietnam.
 
The 11 country members are meeting in Da Nang, Vietnam for the Asia-Pacific Economic Cooperation Leaders’ Week, November 6-11.
 
“The canola industry is urging the federal government to advance the TPP during these discussions,” says Jim Everson, President of the Canola Council of Canada (CCC). “Implementing the TPP will increase value-added processing in Canada, maintain existing markets and ensure that Canada remains competitive to other oilseed producing countries.”
 
The CCC notes that while the United States has decided not to proceed with TPP negotiations, implementing an agreement with the remaining 11 countries would provide Canadian canola a competitive advantage over competing oilseed products entering TPP countries, such as U.S. soybean oil into Japan.
 
Source : Steinbachonline

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.